Latest Asx News

INOVIQ's December quarterly update reveals significant progress in its cancer diagnostic and therapeutic programs, including a highly accurate ovarian cancer screening test and promising breast cancer therapeutics, supported by growing EXO-NET customer adoption and a solid cash position.

BluGlass Limited has secured over A$4 million in new contracts and filed three US patents for high-power tunable GaN lasers, reinforcing its leadership in visible laser technology and expanding its footprint in strategic photonics markets.

Nido Education Limited has appointed Adam Lai, former PwC Sydney Managing Partner, as its new CEO starting February 2025, signaling a strategic push for significant expansion over the next five to eight years.

LiveHire’s 2Q25 report reveals a sharp rise in operating cash outflows and a dip in SaaS revenue, offset by strong growth in its North American Direct Sourcing business and a strategic capital raise amid an ongoing takeover.

Pure Hydrogen advances its zero-emission vehicle strategy with key deliveries, US partnerships, and a planned demerger of its natural gas assets into Eastern Gas Limited.

1414 Degrees Ltd reports strong progress in its hydrogen and thermal energy storage projects, securing full funding for commercialisation and advancing key customer agreements. The company is poised to scale its innovative technologies amid ongoing operational enhancements.

Maximus Resources has launched a significant 3,000m RC drilling campaign at its Lefroy Lithium Project, aiming to expand on promising lithium mineralisation at Bird Rock and Kandui under a joint venture with KOMIR.

Winsome Resources has filed a key Technical Report for its Adina Lithium Project and extended payment terms for the Renard Operation acquisition, marking significant progress in project development and regulatory engagement.

Bastion Minerals has completed its acquisition of three high-grade Canadian copper projects and raised AUD$1 million to fund exploration, positioning itself as a growing player in the energy transition metals sector.

ActivEX Limited reported robust exploration progress in Q4 2024, highlighted by significant high-grade gold intercepts at Mt Hogan and the securing of a rare earth elements tenement at Doonkuna. The company maintains a cautious cash position supported by a substantial loan facility.

Amplia Therapeutics has completed enrolment for its ACCENT Phase 2a trial in advanced pancreatic cancer two months early, reporting encouraging partial response rates and improved patient outcomes.

Lumos Diagnostics reported a robust Q2 FY25 with a 71% revenue increase to US$2.9 million, driven by strong product and service sales, alongside a strategic US$3 million BARDA partnership to advance its FebriDx test.